|
US FDA on LTL adjustments for Nitrosamines
|
|
20
|
951
|
October 8, 2026
|
|
📣 Theoretical and Experimental Assessment of Nitrosamine Risk in Industrial Solvent Recovery -Pub
|
|
3
|
689
|
May 29, 2026
|
|
Something in the air−Unveiling the role of atmospheric nitrogen oxides in nitrosamine formation from amine-containing APIs: Mechanistic insights and risk assessment-Pub
|
|
2
|
550
|
April 28, 2026
|
|
Construction of a modified Arrhenius equation for predicting drug nitrosation in solid dosage form -Pub
|
|
4
|
1241
|
April 21, 2026
|
|
Modeling the Impact of Excipients Selection on Nitrosamine Formation towards Risk Mitigation
|
|
18
|
5570
|
September 20, 2025
|
|
Nitrosamine Risk Mitigation Calculator (by DFE Pharma)
|
|
1
|
1692
|
August 11, 2025
|
|
Synthesis of Nitroso Derivatives of Dihydropyridine Calcium Channel Blockers
|
|
5
|
1017
|
July 31, 2025
|
|
📖 Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines-Pub
|
|
2
|
1259
|
May 27, 2025
|
|
FDA Generic Drugs Forum - Bioequivalence Approaches
|
|
2
|
1207
|
April 22, 2025
|